PMEF
IART icon

Point72 Middle East FZE’s Integra LifeSciences IART Stock Holding History

Point72 Middle East FZE’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-35,566
Closed -$1.46M – 1639
2023
Q2 		$1.46M Buy
+35,566
New +$1.71M 0.04% 467

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Middle East FZE's IART Position: Q3 2023 in Review

Point72 Middle East FZE sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 35,566 shares — an estimated $1.46M sold.

Point72 Middle East FZE first reported a position in IART in Q2 2023 and held it in 1 quarter. The position peaked at $1.46M in Q2 2023. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

  • Point72 Middle East FZE reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 35,566 Integra LifeSciences shares in Q3 2023, an estimated $1.46M.
  • Point72 Middle East FZE first reported a position in Integra LifeSciences in Q2 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's Integra LifeSciences position peaked at $1.46M in Q2 2023.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.